Vimarsana
Biggest News Aggregation in the World

Page 35 - Albert Bourla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Albert Bourla Today - Breaking & Trending Today

AI fake news fears send chill through Davos as world braces for Trump v Biden re-run - Vimarsana News

AI fake news fears send chill through Davos as world braces for Trump v Biden re-run

Davos, which plays host to global elites at the World Economic Forum, has this week been dominated by the opportunities and dangers posed by AI.

OpenAI CEO Sam Altman Unveils Vision for AI's Impact on Economy and Society at WEF Davos - Vimarsana News

OpenAI CEO Sam Altman Unveils Vision for AI's Impact on Economy and Society at WEF Davos

In a thought-provoking session at the World Economic Forum in Davos, Sam Altman, CEO of OpenAI, shared his vision for the future trajectory of artificial

Pfizer, Autodesk, AbbVie And More: CNBC's 'Final Trades' - Autodesk (NASDAQ:ADSK), AbbVie (NYSE:ABBV) - Vimarsana News

Pfizer, Autodesk, AbbVie And More: CNBC's 'Final Trades' - Autodesk (NASDAQ:ADSK), AbbVie (NYSE:ABBV)

On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund (NYSE: XLV)

Pfizer Insider Trading: Former Employee Found Guilty Of Trading On Successful COVID-19 Paxlovid Trial News - Pfizer (NYSE:PFE) - Vimarsana News

Pfizer Insider Trading: Former Employee Found Guilty Of Trading On Successful COVID-19 Paxlovid Trial News - Pfizer (NYSE:PFE)

Amit Dagar, ex-Pfizer lead, guilty of securities fraud for insider trading on COVID drug trial info.

Ex-Pfizer Employee Convicted for Insider Trades Ahead of Positive Paxlovid Data - Vimarsana News

Ex-Pfizer Employee Convicted for Insider Trades Ahead of Positive Paxlovid Data

The former Pfizer statistician worked on the clinical trial for the Covid-19 drug Paxlovid. A jury found the employee guilty of insider trading for transactions made before clinical data for the antiviral were publicly announced.